期刊名称：PREVENTIVE MEDICINE
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Preventive Medicine
|
Recognized for its authoritative contributions to the entire field
of preventive medicine and public health, Preventive Medicine: An International Journal Devoted to Practice and Theory is a respected source of information on applied research into all aspects of prevention.
Special Features include Original Research, Pertinent Issues and Innovation in:
Cancer
Cardiovascular disease
Health education
Individual and population risk factor screening
Respiratory and infectious disease
Public health planning
Tobacco and other substance abuse
Stroke and hypertension
Other lifestyle-related diseases |
|
Instructions to Authors
Preventive Medicine is an international journal, publishing original, scholarly manuscripts pertaining to preventive medicine and public health. Topics of interest include, but are not limited to, cardiovascular disease, cancer, and other preventable diseases, lifestyle disorders and interventions, the effects of socioeconomic status on health, and environmental and occupational health. Article types typically include original research, editorials, review articles, clinical practice reports, theoretical papers, book reviews, and letters to the editor.
Manuscripts are assessed on the basis of importance, scientific merit, originality, clarity, conciseness, and interest. Most manuscripts will receive an external review by two to four peer reviewers. The manuscript and its external reviews will also be evaluated by an Associate Editor or Consultant with expertise in the field of discussion. The final editorial decision rests with the Editor-in-Chief. Manuscripts judged inappropriate for the journal are returned immediately to the authors.
Submission of Manuscripts
For both new and revised manuscripts: one original manuscript (single-sided master), three copies (double-sided duplicates preferred for environmental reasons), and the electronic version should be submitted to:
Daniel W. Nixon, M.D., Editor-in-Chief
Preventive Medicine
525 B Street, Suite 1900
San Diego, CA 92101-4495, USA
Telephone: (619) 699-6852; Fax: (619) 699-6700
E-mail:pm@elsevier.com
When submitting the two-sided copies, please make sure any artwork (i.e., laser copies of line art) is sent single-sided. There are no submission fees or page charges. Each manuscript should be accompanied by a letter outlining the basic findings of the paper and their significance.
Electronic Submission. Authors are requested to transmit the text and art of the manuscript in electronic form, via computer disk, e-mail (pm@elsevier.com), or FTP (ftp.elsevier.com, with username anon and password essd4acc), each time a new version is submitted. Submission as an e-mail attachment is acceptable provided that all files are included in a single archive the size of which does not exceed 2 megabytes. Hard-copy printouts of the manuscript and art that exactly match the electronic file must be supplied. The manuscript will be edited according to the style of the journal, and authors must read the proofs carefully.
Manuscripts are accepted for review with the understanding that no substantial portion of the study has been published or is under consideration for publication elsewhere and that its submission for publication has been approved by all of the authors and by the institution where the work was carried out. Manuscripts that do not meet the general criteria or standards for publication in Preventive Medicine will be immediately returned to the authors, without detailed review.
Copyright and Permissions
Upon acceptance of an article, authors will be asked to transfer copyright (for more information on copyright, see http://authors.elsevier.com). This transfer will ensure the widest possible dissemination of information. A letter will be sent to the corresponding author confirming receipt of the manuscript. A form facilitating transfer of copyright will be provided after acceptance.
If material from other copyrighted works is included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases: contact Elsevier Global Rights Department, P.O. Box 800, Oxford OX5 1DX, UK; phone: (+44) 1865 843830, fax: (+44) 1865 853333, e-mail: permissions@elsevier.com.
Preparation of Manuscripts
Articles should be in English, generally not exceed 30 typewritten pages (including references, tables, and figures), be double-spaced, and include marked page numbers. Acknowledgment of all sources of funding and financial involvements related to work must be made, and whether the project was initiated and analyzed by the investigator or by the funding source must be divulged. Abbreviations should be unpunctuated, and gender-neutral language and generic product names used whenever appropriate and possible. Authors are encouraged to include the names, addresses, and phone and fax numbers of one to three individuals they feel would provide the most expert, careful, and unbiased review.
Pages should be numbered consecutively and organized as follows:
The Title Page (p. 1) should include the article title; author(s) name(s) with academic degrees, including affiliation symbols linking them to their affiliations listed on the line below the author(s) line; and the corresponding author's name, address, phone and fax numbers, and e-mail address. Titles should be brief and informative.
The Abstract (p. 2) must be less than 200 words, subdivided under the headings of background, methods, results, and conclusions. Abstracts should include sample sizes if populations are being quantitatively examined. Below the abstract, 3 to 10 MESH-heading keywords must be provided.
The Précis should be no longer 30 words, include the study's main conclusions, and preferably contain the study's sample size. This should be provided on a separate, unnumbered page.
The Introduction should be as concise as possible, without subheadings. It must clearly state the manuscript's importance and its claim to novelty, regarding both the work of prior investigators and, if relevant, other work of the authors. Requests for clearer expressions and more specific delineations of novelty and importance are the most frequent requests made of authors at the revision stage.
Methods should be sufficiently detailed to enable the experiments to be reproduced. The section should include mention of ethical approval by a (human subjects) review board.
Results and Discussion may be combined and may be organized into subheadings. Where possible, this section should include a figure summarizing the manuscript's main findings. Statistical significance should always be defined with specific P values.
Acknowledgments should be brief and should precede the references.
References should be cited in the text in square brackets in numerical order, conform to the Vancouver style, and be correct and complete. Only articles that have been published or are in press should be included in the references. Unpublished results or personal communications should be cited as such in the text. If there are more than six authors/editors, list only the first three followed by et al.
[1] Sahyoun NR, Brett KM, Hochberg MC, Pamuk ER. Estrogen replacement therapy and incidence of self-reported physician-diagnosed arthritis. Prev Med 1999;28:458-64.
[2] Morley P. Preventive therapy in asthma. San Diego: Academic Press; 1991, p. 304-6.
[3] Kopriva P. Women in medicine. In: Friedman E, editor. An unfinished revolution: women and health care in America. New York: United Fund; 1994, p.1233-34.
[4] Burns DM, Garfinkel L, Samet JM, editors. Changes in cigarette-related disease risks and the implication for prevention and control. Smoking and tobacco control, Monogr. 8 Washington: National Institutes of Health, National Cancer Institute; 1997 [NIH Publication No. 97-4213]
Figures should be in a finished form suitable for publication. Number figures consecutively with Arabic numerals, and indicate the top and the authors on the back of each figure. Lettering on drawings should be professional quality or generated by high-resolution computer graphics and must be large enough to withstand appropriate reduction for publication. Please visit our Web site at http://authors.elsevier.com/artwork for detailed instructions on preparing electronic artwork.
Tables should be numbered consecutively with Arabic numerals in order of appearance in the text. Type each table double-spaced on a separate page with a short descriptive title typed directly above and with essential footnotes below. Authors should submit complex tables as camera-ready copy.
Proofs
Proofs will be sent to the corresponding author. To avoid delay in publication, only necessary changes should be made, and proofs should be returned promptly. Authors will be charged for alterations that exceed 10% of the total cost of composition.
Checklist (see above for further explanation)
- Original 1-sided manuscript, three 2-sided copies
- Electronic version
- Appropriate cover letter (signed, with necessary statements)
- Correct format (double-spaced, marked page numbers, references checked)
- Title page complete with brief and informative title
- Structured abstract (background, methods, results, and conclusions), followed by keywords
- Introduction with explanation of manuscript's novelty and importance
- Gender-neutral language
- Relevant financial relationships noted
- Précis
Editorial Board
Founding Editor:
E.L. Wynder, MD
Editor-in-Chief:
D.W. Nixon, MD, American Health Foundation
Managing Editor:
H. Rabinowitz, The Reference Work
Editorial Coordinator:
I. Hoffmann, American Health Foundation
Associate Editors:
W.T. Friedewald, MD, Metropolitan Life Insurance Company, New York, USA
S. Jonas, MD, MPH, State University of New York at Stony Brook, School fo Medicine, New York, USA
L.H. Kuller MD, Dr.PH, University of Pittsburgh, Graduate School of Public Health, Pennsylvania, USA
A. Morabia, MD, Ph.D., University Canton Hospital, Geneva, Switzerland
K.A. Resnicow, Ph.D., Emory University, Rollins School of Public Health, Georgia, USA
B.K. Rimer, MPH, Dr. PH, Duke University Medical Center, North Carolina, USA
W.J. Rogan, MD, MPH, Research Triangle Park, North Carolina, USA
J.H. Weisburger, PH.D, MDhc, Director Emeritus, American Health Foundatin, New York, USA
M.A. Winkleby, Ph.D., Stanford Center for Research in Disease Prevention, California, USA
K.A. Schneider, MD, Medical Student / Resident Representative, Columbia University, New York, USA
Consultants:
E.E. Baulieu, MD, Ph.D, Bicêtre, France
G.S. Berenson, MD, Louisiana, USA
E. Bjelke, MD, MS, Ph.D., Bergen, Norway
L. Breslow, MD, Ph.D, California, USA
J.A. Brody, MD, Illinois, USA
C. Cabrol, MD, Ph.D, Paris, France
L. Domellöf, MD, Ph.D, Örebro, Sweden
J. Fraumeni, Jr., MD, Maryland, USA
S. Garattini, MD, Milan, Italy
P. Greenwald, MD, Maryland, USA
S.B. Hulley, MD, MPH, California, USA
D.T. Janerich, DDS, MPH, Utah, USA
U. Keil, MD, MPH, Ph.D, Münster, Germany
R.V. Luedpker, Minnesota, USA
J.D. Matarazzo, MS, Ph.D, Oregon, USA
A.B. Miller, MBBChir., MPCP, MFCM, Ontario, Canada
B. Modan, MD, Tel Aviv, Israel
D.K. Parkinson, MD, New York, USA
P. Puska, MD, M.Pol.Sci, Helsinki, Finland
K. Shanmugaratnam, MD, Singapore
D. Tamir, MD, Jerusalem, Israel
S. Tominaga, MD, MPH, Nagoya, Japan
|
